Which Technology Merits Payment in Diabetes Care?

Robert Gabbay, MD, PhD, FACP; Dennis P. Scanlon, PhD; and Kenneth Snow, MD, MBA, remark that with new and constantly improving technologies on the market, only some have demonstrated evidence in clinical trials that they improve outcomes and reduce costs.

Leave a Reply

Your email address will not be published. Required fields are marked *